«Forms Approved Through 08/31/2018 Instructions for PHS 2590 Revised 03/2016 OMB No. 0925-0002 TABLE OF CONTENTS Notable and Upcoming Changes 1. ...»
Peer-reviewed trainee publications that arise from support of the training grant must be reported in accord with Section 2.6.E., Publications above. It will be necessary for the Program Director to add PHS 2590 25 trainee publications to his/her MyBib so that a list of these publications is appropriately generated.
Trainee publications may be placed in the section entitled “Other Publications” in MyBib. My Bibliography will display the correct text format, and if available, include the appropriate reference number (PMID, PMCID, or NIHMSID), and compliance status for NIH recipients.
Citations that are not covered by the NIH Public Access Policy but are publicly available in a free, online format may include URLs or the PubMed Central numbers (PMCID) along with the full reference.
FORM PAGE 6 Facilities and Administrative (Indirect) Costs Facilities and Administrative (F&A) costs under institutional Kirschstein-NRSAs, other than those issued to State or local government agencies, will be awarded at 8 percent of total modified direct costs (excluding the tuition/fees category and sub-grants and contracts in excess of $25,000). Equipment is also excluded on those training grants where Training Related Expenses are not calculated on a lumpsum basis, such as the MARC or COR Honors Undergraduate Research Training Grants. The treatment of health insurance will vary according to the policies under which a Kirschstein-NRSA award was made (for details, see Item 2). State and local government agencies will receive awards at their full Facilities and Administrative cost rate.
5.1.8 All Personnel Report FORM PAGE 7 Not applicable.
6. Additional Instructions for Preparing a Progress Report for an SBIR/STTR Award - Not Applicable to NIH and AHRQ
For SBIRs/STTRs awarded by NIH, use the RPPR instructions at:
AHRQ does not issue SBIR/STTR awards.
For SBIRs/STTRs awarded by other agencies, follow the instructions in Sections 1 and 2 of this
document. Additionally, all SBIR and STTR progress reports must include the following information:
What is the impact on technology transfer?
Describe ways in which the project made an impact, or is likely to make an impact, on
commercial technology or public use, including:
• transfer of results to entities in government or industry;
• instances where the research has led to the initiation of a start-up company; or
• adoption of new practices.
Report on the status of commercialization activities resulting from the award:
Nothing to report or select one or more of the following:
Sales = $_______
6.1 SBIR/STTR Fast-Track Phase II Applications An SBIR/STTR Fast-Track Phase II application may be funded following submission of an original PHS 2590 Non-competing Continuation Progress Report. Funding for the Phase II application will be contingent upon (1) assessment of the Phase I progress report and determination that the Phase I goals and milestones were achieved; (2) an update (as necessary) of the Commercialization Plan; (3) determination of the project's potential for meeting the mission of the awarding component and for commercial success; (4) review and approval of other documents necessary for continuation; and (5) availability of funds.
The grants management and program staff of the awarding IC will review the SBIR/STTR Fast-Track Phase II application. If the continuation request is not approved, then written notification will be sent to the applicant.
To complete the SBIR/STTR Fast-Track Phase II application, follow the directions under Sections 1 and 2 of this document, with the following exceptions:
1. The PHS 2590 should be submitted in accordance with the instructions in the terms and condition of award found on the Notice of Award.
2. The research plan, should include the following information:
a. A Phase I Final Progress Report: Follow the application instructions in the General Application Guide for NIH and Other PHS Agencies, Research Plan Form, Item 3, Research Strategy, Progress Report for Phase II and Phase II Competing Renewal and Revision Applications at http://grants.nih.gov/grants/how-to-apply-application-guide.htm.
b. A section labeled Milestones (l) identifying either the milestones described in the original Phase I application as approved by the peer reviewers or the milestones modified by the
If yes, please explain (e.g., decreased level of effort from 4.8 calendar year (CY) months to 3.6 CY months); if no, so state. A significant change in level of effort is defined in Federal regulations as a 25 percent reduction in time devoted to the project, from what was approved at the time of award. For example, if a NoA-specified individual on the project is expected to reduce his/her effort from 4.8 CY months to 3.6 CY months, which represents a 25 percent reduction in the level of effort, an explanation must be provided.
b. Is it anticipated that an estimated unobligated balance (including prior year carryover) will be greater than 25% of the current year’s total approved budget?